Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Angel Yeast lanza una cepa de levadura probiótica eficaz contra la diarrea
  • USA - Français
  • USA - Deutsch
  • Brazil - Português
  • Latin America - español
  • USA - English

angel_logo_Logo

News provided by

Angel Yeast

Sep 02, 2021, 14:43 ET

Share this article

Share toX

Share this article

Share toX

-Angel Yeast lanza Saccharomyces Boulardii Bld-3 patentada, una cepa de levadura probiótica eficaz contra la diarrea

YICHANG, China, 2 de septiembre de 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" o "Angel"), una empresa de levaduras de alta tecnología que cotiza en bolsa en China, ha anunciado que su equipo de I+D nutricional ha desarrollado una nueva cepa de levadura probiótica, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3), y una innovadora tecnología de producción para el nuevo producto. El probiótico de levadura patentado está diseñado para tratar la diarrea y reforzar la salud del sistema digestivo e inmunitario en niños y adultos.

Continue Reading
Angel Yeast announced it has developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) to treat diarrhea and strengthen healthy digestive and immune systems in children and adults.
Angel Yeast announced it has developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) to treat diarrhea and strengthen healthy digestive and immune systems in children and adults.

"Saccharomyces boulardii (S. boulardii) es un tipo de probiótico que se ha considerado una intervención nutricional crucial en el tratamiento de la diarrea. La nueva cepa de levadura probiótica desarrollada por el Angel Nutrition & Health Technical Center, S. boulardii Bld-3, es otra adición innovadora a la familia de S. boulardii que ha demostrado ser eficaz para acelerar la recuperación de la diarrea aguda y es beneficiosa para la salud intestinal a largo plazo", dijo el Dr. Zhang Yan, responsable tecnológico de Angel Nutritech, establecida en 1992 por Angel Yeast centrada en la nutrición y la salud humana para desarrollar y suministrar productos acabados destacados a las industrias globales de cuidado humano.

La COVID-19 ha provocado que más personas presten atención a su salud y que se centren más en las medidas de precaución y en los productos sanitarios que previenen enfermedades y refuerzan su sistema inmunitario. En Google Trends, las consultas de búsqueda "salud intestinal" y "probiótico" han experimentado varios picos durante la pandemia. En cuanto a la salud gastrointestinal, las búsquedas de palabras clave relacionadas con los probióticos también han alcanzado un récord este año, lo que indica un mayor reconocimiento de su sólida capacidad para restaurar y mantener un sistema digestivo saludable para los seres humanos.

El uso de S. boulardii para el tratamiento de adultos y niños con diarrea ha sido ampliamente prescrito por médicos y gastroenterólogos durante décadas y su eficacia para combatir una serie de condiciones gastrointestinales está bien documentada en la literatura médica. Un estudio publicado en el Chinese Journal of Pediatrics concluye que ciertos tipos de probióticos pueden reducir la gravedad y la duración de la diarrea. Entre ellos, el Lactobacillus rhamnosus GG y el S. boulardii son los dos probióticos más eficaces para el tratamiento de la diarrea.

A diferencia de los probióticos de Lactobacillus, el S. boulardii Bld-3 de Angel se desarrolla mediante el proceso de lecho fluidizado a baja temperatura. La tecnología de protección única de la empresa le permite formar rápidamente una densa cáscara de levadura que encierra los probióticos de levadura activa atrapados en su interior. Este proceso refuerza la resistencia de la levadura al ácido gástrico y a las sales biliares, lo que permite su aplicación en una amplia variedad de productos probióticos finales.

La S. boulardii Bld-3 de Angel es un ingrediente adecuado para una amplia gama de suplementos dietéticos probióticos. Gracias al mayor tamaño de los probióticos de levadura, que es diez veces mayor que el de los probióticos de Lactobacillus, es más probable que formen un efecto de ocupación de espacio en el tracto intestinal y sean resistentes a los antibióticos.

Angel Yeast, uno de los mayores proveedores de derivados de levadura del mundo, cuenta con más de tres décadas de experiencia en el desarrollo y la producción de productos de levadura. Además de S. boulardii Bld-3, Angel Yeast también produce el probiótico Saccharomyces cerevisiae y otras amplias gamas de ingredientes funcionales de levadura, con varios productos nuevos en proyecto, como Kluyveromyces marxianus. En la actualidad, los productos probióticos producidos por Angel Yeast se han vendido en Europa y Norteamérica.

Acerca de Angel Yeast

Fundada en 1986, Angel Yeast Co., Ltd se especializa en la producción de levadura y derivados de levadura. Su gama de productos incluye levadura e ingredientes de panadería, soluciones de dim sum chinas, extracto de levadura-sabor, salud humana, nutrición animal, cuidado de las plantas, elaboración de cerveza y biocombustibles, nutrición microbiana y enzimas. En la actualidad, Angel Yeast cuenta con 11 bases internacionales de producción avanzada en China, Egipto y Rusia, y suministra productos y servicios a más de 150 países y regiones de todo el mundo.

Foto - https://mma.prnewswire.com/media/1607484/1.jpg 
Logo - https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg 

Related Links

www.angelyeast.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Clôture des finales de la coupe Angel Yeast et de la conférence sur le développement de l'industrie

Clôture des finales de la coupe Angel Yeast et de la conférence sur le développement de l'industrie

Les finales du 8e concours Angel Yeast Cup Chinese Fermented Dim Sum et la 12e conférence sur le développement de l'industrie des aliments à base de...

Finale des Angel Yeast Cup und Abschluss der Industry Development Conference

Finale des Angel Yeast Cup und Abschluss der Industry Development Conference

Die Finale des 8. Angel Yeast Cup Chinese Fermented Dim Sum Contest und die 12. Fermented Flour-Based Food Industry Development Conference (Konferenz ...

More Releases From This Source

Explore

Food & Beverages

Food & Beverages

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Fitness/Wellness

Fitness/Wellness

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.